ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

EARLY DIAGNOSIS OF CROHN'S DISEASE SYMPTOMS AND MANAGEMENT

AUTHORS:

1Nuha Abdulrahman Banjar,2Shahd Abdullah Abdulwahab , 3 Sara Edrees AlDrees,4Shejoun yazeed Binsaeed , 5Norah S. Alajmi , 6Habibah O Sardidi, 7 Malak A. Alsaif , 8 Sahar S. Aldakhil,9 Farah Saleh Aljoufi, 10 Abdulelah Yasser Fakieha,11 Lujain hamad alfayez, 12Ghadah Saad Alshehri, 13Tamadr Mohammed Aldhahri

ABSTRACT:

Crohn's disease is a chronic, relapsing inflammatory condition of the gastrointestinal system. In this review we discuss the management methods and early diagnosis approaches. Recognition of the therapeutic possibility and associated unfavorable occasions is necessary both for providing benefit and for protecting patients from excessive dangers from these therapies. Targeted detailed search was conducted through databases; PubMed/Midline, and Embase, for these articles disusing the diagnosis of crohn's disease symptoms and management, with human subjects published up to end of 2018. Crohn’s disease is a chronic IBD that can impact any type of section of the gastrointestinal tract. It is typically medically taken care of, but a significant percent of patients will need surgical procedure. The objectives of care are to cause and maintain a steroid-free remission, decrease the threat of issues and surgery, and likewise improve the total quality of life. The diagnosis of CD is a medical one and can be quite difficult considered that the here and now signs can be dangerous and nonspecific. Red flag symptoms that call for more assessment consist of weight-loss, bloody diarrhea, iron shortage, and night-time awakenings. In a similar way, considerable family history of IBD, unusual elevations in the c-reactive protein level, sedimentation rates, or various other acute-phase reactants (eg, ferritin and platelets), or reduced B 12 ought to prompt more investigation for feasible CD.

FULL TEXT

Top
  • Follows us on
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.